AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 62 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,296 | +194.7% | 57,149 | +106.3% | 0.00% | – |
| Q3 2022 | $32,000 | +255.6% | 27,704 | +95.7% | 0.00% | – |
| Q2 2022 | $9,000 | -92.9% | 14,159 | -70.7% | 0.00% | – |
| Q1 2022 | $126,000 | -43.5% | 48,312 | -15.7% | 0.00% | – |
| Q4 2021 | $223,000 | -30.1% | 57,307 | -21.7% | 0.00% | – |
| Q3 2021 | $319,000 | +18.1% | 73,165 | +7.5% | 0.00% | – |
| Q2 2021 | $270,000 | +11.1% | 68,030 | +45.3% | 0.00% | – |
| Q1 2021 | $243,000 | -11.3% | 46,826 | -8.5% | 0.00% | – |
| Q4 2020 | $274,000 | -29.7% | 51,167 | -36.3% | 0.00% | – |
| Q3 2020 | $390,000 | +306.2% | 80,327 | +304.6% | 0.00% | – |
| Q2 2020 | $96,000 | -65.8% | 19,851 | -58.9% | 0.00% | – |
| Q4 2019 | $281,000 | +778.1% | 48,336 | +373.5% | 0.00% | – |
| Q3 2019 | $32,000 | -88.5% | 10,209 | -74.6% | 0.00% | – |
| Q1 2019 | $278,000 | +110.6% | 40,160 | +92.2% | 0.00% | – |
| Q4 2018 | $132,000 | -64.9% | 20,895 | -2.6% | 0.00% | – |
| Q3 2018 | $376,000 | – | 21,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |